INSIDERFilingvia Quantisnow
CohBar Inc. logo

CohBar (CWBR) executive Sarret received 2,600,000 Stock Option (Right to buy)

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Joseph J. Sarret (executive at CohBar Inc., CWBR) reported that they received 2,600,000 Stock Option (Right to buy) on May 3, 2021.

Reporting person
Sarret Joseph J.

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
May 3, 2021Grant or award (A)Stock Option (Right to buy)On 2,600,000 Common Stock1+2,600,000--2,600,000 direct

Holdings before and after

  • Stock Option (Right to buy): 0 to 2,600,000 direct

Footnotes from the filing

  1. 1. 25% of the shares subject to the option shall vest on 05/03/2022, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the continuing service of the Reporting Person on each vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Sarret report in this CWBR Form 4?

Joseph J. Sarret (executive at CohBar Inc., CWBR) reported that they received 2,600,000 Stock Option (Right to buy) on May 3, 2021.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CWBR

Earlier insider filings at CWBR

Quantisnow market dataNASDAQ
CohBar Inc. logo
CWBR
CohBar Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Get push alerts for CWBR

Follow CWBR and get a push notification the moment its next story breaks.

Full CWBR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CWBR (CohBar Inc.) and more on Quantisnow.